Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Dec 1;5(6):e001081. doi: 10.1136/esmoopen-2020-001081

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Author (s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ on behalf of the European Society for Medical Oncology.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, any changes made are indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

PMC Copyright notice

ODM-203 best tumour response (RECIST) for FGFR patients (A) and non-FGFR patients (B). ITT 76 patients, 4 patients with low exposure (100–200 mg) and one patient with non-evaluable non-target lesions (600 mg) are not included. Unscheduled visits are included in the data. Transcript of abbreviations: CUP, cancer of unknown primary; FGFR, fibroblast growth factor receptor; GIST, gastrointestinal stromal tumour; H&N, head and neck; mBC, metastatic breast cancer; mCRC, metastatic colorectal cancer; mHCC, metastatic hepatocellular carcinoma; NSCLC, non-small cell lung cancer; RECIST, Response Evaluation Criteria in Solid Tumours; SCC, squamous cell carcinoma; STS, soft-tissue sarcoma.